AzTrials
AzTrials

Emergency LaparotomyPOLONCT05281627

Psycho-Social Outcomes Following Emergency Laparotomy

An observational study of Emergency Laparotomy, run by Cardiff and Vale University Health Board at 2 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

An emergency laparotomy (EmLap) is a life-saving operation; but the aftermath for those that do survive can be lifechanging. Each year, in excess of 25,000 EmLaps are performed in UK. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Emergency Laparotomy
What is being tested?
Emergency Laparotomy
How many people
175 participants
Where
2 sitesUnited Kingdom
Study dates
15 Oct 2021to 30 Sep 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population is all patients who have undergone emergency laparotomy during their admission to hospital, are recovering well and approaching discharge. Participants will be recruited from hospital sites in Wales and Scotland.

Who may be able to join

  • 18 years or above
  • Able to communicate in English
  • Cognitively able to complete the questionnaire
  • Able to provide informed voluntary consent
  • Undergone an EmLap during admission
  • Clinical team anticipate to be "medically fit for discharge" within 48 hours (of consent)

Who cannot join

  • Any terminal diagnosis in which the clinical team do not anticipate life expectancy to exceed 6 months from the time of surgery
  • Acutely unwell at the time of recruitment. These patients may still be eligible and can be re-screened and recruited at a later date, should their condition improve.

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • Julie Cornish

    Cardiff, CF14 4XW

  • Royal Alexandra Hospital

    Paisley, Renfrewshire, PA2 9PJ

Other trials in United Kingdom

About this study

An emergency laparotomy (EmLap) is a life-saving operation; but the aftermath for those that do survive can be lifechanging. Each year, in excess of 25,000 EmLaps are performed in UK. A national effort, through the National Emergency Laparotomy Audit (NELA), has managed to improve peri-operative care, and reduce 30 day mortality from 1 in 4 to less than 1 in 10. Whilst this reduction should be commended, it also means that more patients are surviving with some form of new infirmity.

This infirmity may be short-lived and reversible in some, and yet others may transition into a permanent chronic disease state. The impact of EmLap on those individuals that "do not fully recover" is far-reaching and often interlinked, covering biological, social and psychological domains. This makes it difficult to describe the true problem, i.e. holistic morbidity and suggest an intervention to improve it.

The primary aim of this work is to describe the holistic morbidity of EmLap throughout the first year of a patient's recovery.

Being tested
Emergency Laparotomy
Keywords
Emergency Laparotomy, Laparotomy, Surgical Outcomes, Psychosocial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emergency LaparotomyOther

    All patients undergoing Emergency Laparotomy

Study groups in NCT05281627
Study groupRoleWhat they receive
Emergency Laparotomy PatientsAll adult patients (18+) who have undergone Emergency Laparotomy surgery, are recovering well (no illness which is expected to limit life to <6m post op) and have sufficient English-language and cognitive skills to complete the study questionnaires.
Receives: Other: Emergency Laparotomy
Family CaregiversAdult (18+) family members, close friend or caregivers of the individual who has received EmLap treatment have sufficient English-language and cognitive skills to complete the study questionnaires.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The change in patient reported Quality of Life as assessed by the EuroQuol 5-Dimension Health-related Quality of Life instrument (EQ-5D)

    Patient reported Quality of Life will be measured at 3 time points post-discharge. Reduction of EQ-5D 3-Level scale (min.5; max 15) and EQ-5D Visual Analogue Scale (min 0; max. 100) represent improved quality of life.

    Measured: 12 months

Secondary outcomes (12)
  1. Establishing the patient definition of 'Recovery' following Emergency Laparotomy using qualitative methods

    Semi-structured qualitative interviews will be conducted with approximately 15 Emergency Laparotomy patients, at 6-months post-discharge from hospital. The interview will evaluate:

    1. what patients consider to constitute 'recovery' following emergency laparotomy B) what factors influence achieving 'recovery' C) the timelines linked to a) and b)

    Measured: 12 months

  2. Change in Fatigue Severity Score

    Fatigue severity score (FSS) to assess physical health. Measured at 3 time-points post-operatively and scored from 9 (min.) to 63 (max.), with increase in total score represents greater fatigue severity/ reduced physical health.

    Measured: 12 months

  3. Change in Body Mass Index

    Body Mass Index (BMI) to assess physical health. Weight and Height will be recorded in kg and cm (respectively) at 3 time-points and BMI will be calculated and reported in terms of kg/m^2.

    Measured: 12 months

  4. Change in Rockwood Frailty Score

    Rockwood Frailty Score to asses physical health. Collected at 3 time-points and scored from 1 (min.) to 9 (max.), where greater score represents increased frailty. Only validated for use in the over 65's

    Measured: 12 months

  5. Change in Gastro-Intestinal Quality of Life Index

    Gastro-intestinal Quality of Life Index (GIQLI) to assess in physical health. Collected at 3 time-points, total score calculated from 0 (min.) to 144 ( max.), where greater total score represents improved GI health related QoL.

    Measured: 12 months

  6. Change in International Trauma Questionnaire score

    International Trauma Questionnaire to assess mental-health. Collected at 3 timepoints. Scored in accordance with assessment guidance to determine clinical signs of (complex) Post-Traumatic Stress Disorder.

    Measured: 12 months

  7. Change in Patient Health Questionnaire score

    Patient Health Questionnaire (PHQ9) to assess mental-health. Collected at 3 timepoints and scored from 0 (min.) to 27 (max.), where greater score represents increased depression severity.

    Measured: 12 months

  8. Change in Generalised Anxiety Disorder assessment score

    Generalised Anxiety Disorder assessment (GAD7) to assess mental-health. Measured at 3 timepoints from 0 (min.) to 21 (max.), where greater score represents increased anxiety severity.

    Measured: 12 months

  9. Changes in Community Integration Questionnaire score

    Community Integration Questionnaire (CIQ) to determine changes in social integration. Scored between 0 (min.) and 35 (max.), where greater score represents reduced social integration.

    Measured: 12 months

  10. Change in sexual function

    Single question regarding change in sexual function (min 0; max 5), where greater score represents increased sexual impairment

    Measured: 12 months

  11. Change in employment status

    Single question regarding change in employment status (yes/no).

    Measured: 12 months

  12. The changes in care burden as assessed by the Modified Caregiver Strain Index (MCSI)

    Caregiver- reported burden will be measured at 3 timepoints post-discharge. Increase in total score of the Modified Caregiver Strain Index (MCSI) (min. 0; max. 26), represents greater burden on caregiver.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2022
  2. Study start15 Oct 2021
  3. Primary completion30 Sep 2023 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
175 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05281627
Sponsor's protocol ID
8160
Acronym
POLO
Status last verified
Mar 2023
First submitted
29 Nov 2021
Last updated
20 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Silva L, Abbas Mohamed S, Meggy A, Ng JH, Torkington J, Moug S, Watts T, Bisson J, Cornish JA. Psychosocial outcomes following emergency laparotomy (POLO) study: a study protocol for a multicentre mixed-methods prospective cohort study assessing the psycho-social outcomes following emergency laparotomy in adults. BMJ Open. 2024 Jul 9;14(7):e081821. doi: 10.1136/bmjopen-2023-081821.

    PubMed 38986553

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Laparotomy, run by Cardiff and Vale University Health Board at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The change in patient reported Quality of Life as assessed by the EuroQuol 5-Dimension Health-related Quality of Life instrument (EQ-5D) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05281627, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in